We are live on ! Find out more
ACM

Alethea Capital Management Portfolio holdings

AUM $195M
1-Year Est. Return 51.17%
This Fund
S&P 500
This Quarter Est. Return
+18.08%
1 Year Est. Return
+51.17%
3 Year Est. Return
+200.24%
5 Year Est. Return
+277.75%
10 Year Est. Return
+2,049.08%
AUM
$86.7M
AUM Growth
+$5.27M
Cap. Flow
-$6.95M
Cap. Flow %
-8.02%
Top 10 Hldgs %
91.75%
Holding
53
New
2
Increased
2
Reduced
9
Closed
18

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$517K
2
CME icon
CME Group
CME
+$505K
3
GRMN
Garmin
GRMN
+$472K
4
GILD icon
Gilead Sciences
GILD
+$455K
5
AXSM icon
Axsome Therapeutics
AXSM
+$451K

Sector Composition

Rank Sector Weight
1 Healthcare 86.4%
2 Industrials 1.99%
3 Financials 1.67%
4 Technology 1.49%
5 Consumer Staples 1.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
51
AT&T
T
$163B
-29,326
Closed -$440K
WEC icon
52
WEC Energy
WEC
$35.1B
-5,300
Closed -$427K
XEL icon
53
Xcel Energy
XEL
$48.8B
-7,524
Closed -$431K

Similar funds

Alethea Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Alethea Capital Management held 53 positions worth $86.7M, up 6.5% from $81.4M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Alethea Capital Management withdrew a net $6.95M in Q4 2023, closing 18 positions and reducing 9 holdings. Its most notable exit was AbbVie, an estimated $517K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 81% a quarter earlier, followed by Industrials and Financials.

Against the trend, Alethea Capital Management opened a new position in Vanguard Morningstar Small-Cap Growth ETF worth $1.84M.

  • Alethea Capital Management's largest Q4 2023 buy was Vanguard Morningstar Small-Cap Growth ETF: 7,625 shares worth $1.84M.
  • Alethea Capital Management added most to Bank of America in Q4 2023, an estimated $262 increase.
  • Alethea Capital Management's biggest Q4 2023 reduction was Axsome Therapeutics, cutting an estimated $451K.
  • Alethea Capital Management fully exited AbbVie in Q4 2023, selling an estimated $517K.
  • Alethea Capital Management's ten largest holdings make up 92% of its $86.7M portfolio in Q4 2023.
  • Alethea Capital Management opened 2 new positions and closed 18 in Q4 2023.
  • Alethea Capital Management's portfolio value rose 6.5% quarter-over-quarter to $86.7M.

Based on Alethea Capital Management's 13F filing for Q4 2023, filed 15 Feb 2024.